{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:49:39Z","timestamp":1792712979633,"version":"4.5.0"},"reference-count":202,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1053\/j.seminoncol.2014.12.027","type":"journal-article","created":{"date-parts":[[2015,4,3]],"date-time":"2015-04-03T02:50:27Z","timestamp":1428029427000},"page":"223-246","source":"Crossref","is-referenced-by-count":136,"title":["Kaposi Sarcoma\u2013Associated Herpesvirus-Associated Malignancies: Epidemiology, Pathogenesis, and Advances in Treatment"],"prefix":"10.1053","volume":"42","author":[{"given":"Manisha","family":"Bhutani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N.","family":"Polizzotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Uldrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Yarchoan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2014.12.027_bib1","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","article-title":"Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u05f3s sarcoma","volume":"266","author":"Chang","year":"1994","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJM199505043321801","article-title":"Detection of herpesvirus-like DNA sequences in Kaposi\u05f3s sarcoma in patients with and without HIV infection","volume":"332","author":"Moore","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/archinte.1996.00440020112014","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus and Kaposi\u05f3s sarcoma in Africa. Uganda Kaposi\u05f3s Sarcoma Study Group","volume":"156","author":"Chang","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib4","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(95)90642-8","article-title":"Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi\u05f3s sarcoma","volume":"345","author":"Dupin","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib5","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u05f3s disease","volume":"86","author":"Soulier","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib7","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/bjc.1998.717","article-title":"The geographical distribution of Kaposi\u05f3s sarcoma and of lymphomas in Africa before the AIDS epidemic","volume":"78","author":"Cook-Mozaffari","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib8","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1002\/1097-0142(197812)42:6<2626::AID-CNCR2820420618>3.0.CO;2-7","article-title":"Association of Kaposi\u05f3s sarcoma and prior immunosuppressive therapy: a 5-year material of Kaposi\u05f3s sarcoma in Norway","volume":"42","author":"Klepp","year":"1978","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib9","first-page":"305","article-title":"Kaposi\u05f3s sarcoma and Pneumocystis pneumonia among homosexual men\u2014New York City and California","volume":"30","year":"1981","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0002-9343(84)90669-7","article-title":"Acquired immune deficiency syndrome (AIDS) trends in the United States, 1978-1982","volume":"76","author":"Selik","year":"1984","journal-title":"Am J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0140-6736(90)90001-L","article-title":"Kaposi\u05f3s sarcoma among persons with AIDS: a sexually transmitted infection?","volume":"335","author":"Beral","year":"1990","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib12","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S0140-6736(95)91619-9","article-title":"Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi\u05f3s sarcoma","volume":"346","author":"Whitby","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJM199607253350403","article-title":"Seroconversion to antibodies against Kaposi\u05f3s sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi\u05f3s sarcoma","volume":"335","author":"Gao","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","article-title":"A review of human carcinogens--Part B: biological agents","volume":"10","author":"Bouvard","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/jnci\/djr076","article-title":"Cancer burden in the HIV-infected population in the United States","volume":"103","author":"Shiels","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib16","article-title":"Estimated HIV incidence in the United States, 2007\u20132010","year":"2012","journal-title":"HIV Surveillance Supplemental Report"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib17","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ijc.28661","article-title":"Trends in the incidence of cancer in Kampala, Uganda 1991-2010","volume":"135","author":"Wabinga","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib18","doi-asserted-by":"crossref","first-page":"e1004046","DOI":"10.1371\/journal.ppat.1004046","article-title":"Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome","volume":"10","author":"Labo","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib19","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm0896-925","article-title":"KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi\u05f3s sarcoma","volume":"2","author":"Gao","year":"1996","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(96)07560-5","article-title":"Prevalence of Kaposi\u05f3s sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen","volume":"348","author":"Simpson","year":"1996","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2010.02.015","article-title":"Detection of antibodies to Kaposi\u05f3s sarcoma-associated herpesvirus: A new approach using K8.1 ELISA and a newly developed recombinant LANA ELISA","author":"Mbisa","year":"2010","journal-title":"J Immunol Methods"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib22","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/00126334-200004010-00011","article-title":"Identifying human herpesvirus 8 infection: performance characteristics of serologic assays","volume":"23","author":"Engels","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1128\/CVI.00474-08","article-title":"Four-antigen mixture containing v-cyclin for serological screening of human herpesvirus 8 infection","volume":"16","author":"Burbelo","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1386-6532(01)00205-0","article-title":"Genotypic analysis at multiple loci across Kaposi\u05f3s sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism","volume":"23","author":"Zong","year":"2002","journal-title":"J Clin Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jama.287.2.221","article-title":"Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic","volume":"287","author":"Osmond","year":"2002","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/jnci\/90.5.395","article-title":"Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy","volume":"90","author":"Whitby","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib27","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1086\/315456","article-title":"Human herpesvirus 8 in Brazilian Amerindians: a hyperendemic population with a new subtype","volume":"181","author":"Biggar","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib28","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3201\/eid0705.017522","article-title":"Human herpesvirus-8 and other viral infections, Papua New Guinea","volume":"7","author":"Rezza","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1743-422X-7-62","article-title":"Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors","volume":"7","author":"Wang","year":"2010","journal-title":"Virol J"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib30","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/jmv.10136","article-title":"High prevalence of human herpesvirus 8 (HHV-8) infection in south Texas children","volume":"67","author":"Baillargeon","year":"2002","journal-title":"J Med Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1056\/NEJM199804023381403","article-title":"Sexual transmission and the natural history of human herpesvirus 8 infection","volume":"338","author":"Martin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib32","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/339605","article-title":"Correlates of prevalent and incident Kaposi\u05f3s sarcoma-associated herpesvirus infection in men who have sex with men","volume":"185","author":"Casper","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2334-7-143","article-title":"Incidence of human herpesvirus 8 (HHV-8) infection among HIV-uninfected individuals at high risk for sexually transmitted infections","volume":"7","author":"Giuliani","year":"2007","journal-title":"BMC Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib34","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJM199906173402403","article-title":"Antibodies against human herpesvirus 8 in black South African patients with cancer","volume":"340","author":"Sitas","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib35","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1086\/600103","article-title":"Kaposi sarcoma-associated herpesvirus (KSHV) seroprevalence in population-based samples of African children: evidence for at least 2 patterns of KSHV transmission","volume":"200","author":"Butler","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/QAI.0b013e31828a7056","article-title":"Risk factors for seropositivity to Kaposi sarcoma-associated herpesvirus among children in Uganda","volume":"63","author":"Wakeham","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.qai.0000132495.89162.c0","article-title":"Water, socioeconomic factors, and human herpesvirus 8 infection in Ugandan children and their mothers","volume":"38","author":"Mbulaiteye","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib38","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM200011093431904","article-title":"Mucosal shedding of human herpesvirus 8 in men","volume":"343","author":"Pauk","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1086\/509621","article-title":"Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men","volume":"195","author":"Casper","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib40","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1086\/421466","article-title":"Shedding of human herpesvirus 8 in oral and genital secretions from HIV-1-seropositive and -seronegative Kenyan women","volume":"190","author":"Taylor","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib41","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/jnci\/djg039","article-title":"Human herpesvirus 8 infection and transfusion history in children with sickle-cell disease in Uganda","volume":"95","author":"Mbulaiteye","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/oxfordjournals.aje.a010195","article-title":"Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men","volume":"151","author":"Dukers","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nm0896-918","article-title":"The seroepidemiology of human herpesvirus 8 (Kaposi\u05f3s sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission","volume":"2","author":"Kedes","year":"1996","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/518791","article-title":"Risk factors for human herpesvirus 8 infection among adults in the United States and evidence for sexual transmission","volume":"196","author":"Engels","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib45","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/0140-6736(92)90793-3","article-title":"Risk of Kaposi\u05f3s sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS","volume":"339","author":"Beral","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib46","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/aje\/145.8.673","article-title":"Risk of Kaposi\u05f3s sarcoma and oroanal sexual contact","volume":"145","author":"Grulich","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib47","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.7725108","article-title":"Herpes-like sequences in HIV-infected and uninfected Kaposi\u05f3s sarcoma patients","volume":"268","author":"Ambroziak","year":"1995","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib48","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJM199605023341805","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus DNA sequences in prostate tissue and human semen","volume":"334","author":"Monini","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib49","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1097\/00002030-200210180-00013","article-title":"Correlates of human herpesvirus 8 seropositivity among heterosexual men in Kenya","volume":"16","author":"Baeten","year":"2002","journal-title":"AIDS"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib50","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/QAD.0b013e3282f46582","article-title":"No evidence of sexual transmission of Kaposi\u05f3s sarcoma herpes virus in a heterosexual South African population","volume":"22","author":"Malope","year":"2008","journal-title":"AIDS"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib51","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/598978","article-title":"Lack of evidence for frequent heterosexual transmission of human herpesvirus 8 in Zimbabwe","volume":"48","author":"Campbell","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib52","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1097\/00002030-199818000-00018","article-title":"Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi\u05f3s sarcoma","volume":"12","author":"Renwick","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib53","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM200103013440904","article-title":"Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection","volume":"344","author":"Cannon","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tmrv.2012.04.004","article-title":"The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability","volume":"26","author":"Kleinman","year":"2012","journal-title":"Transfus Med Rev"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib55","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJMoa055009","article-title":"Transmission of human herpesvirus 8 by blood transfusion","volume":"355","author":"Hladik","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib56","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM199811053391903","article-title":"Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients","volume":"339","author":"Regamey","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib57","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nm862","article-title":"Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors","volume":"9","author":"Barozzi","year":"2003","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1399-3062.2007.00284.x","article-title":"Donor-derived human herpes virus 8-related Kaposi\u05f3s sarcoma in renal allograft ureter","volume":"10","author":"Dudderidge","year":"2008","journal-title":"Transpl Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib59","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1111\/j.1600-6143.2009.02816.x","article-title":"The impact of preexisting or acquired Kaposi sarcoma herpesvirus infection in kidney transplant recipients on morbidity and survival","volume":"9","author":"Frances","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib60","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1111\/j.1600-6143.2011.03769.x","article-title":"Primary and reactivated HHV8 infection and disease after liver transplantation: a prospective study","volume":"11","author":"Pietrosi","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib61","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1600-6143.2012.04290.x","article-title":"Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients","volume":"13","author":"Lebbe","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib62","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jnci\/djm010","article-title":"AIDS-related cancer and severity of immunosuppression in persons with AIDS","volume":"99","author":"Biggar","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib63","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1086\/507648","article-title":"Low T cell responses to human herpesvirus 8 in patients with AIDS-related and classic Kaposi sarcoma","volume":"194","author":"Guihot","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib64","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1158\/1055-9965.EPI-11-0777","article-title":"HIV infection, immunodeficiency, viral replication, and the risk of cancer","volume":"20","author":"Silverberg","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib65","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980-2002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib66","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/cncr.25547","article-title":"Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States","volume":"117","author":"Simard","year":"2011","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib67","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/0003-4819-147-12-200712180-00003","article-title":"Brief communication: rituximab in HIV-associated multicentric Castleman disease","volume":"147","author":"Bower","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib68","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1200\/JCO.2007.10.6732","article-title":"Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman\u05f3s disease: ANRS 117 CastlemaB Trial","volume":"25","author":"Gerard","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib69","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of cancer risk among US solid organ transplant recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib70","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-6143.2012.04294.x","article-title":"Incidence of primary and second cancers in renal transplant recipients: a multicenter cohort study","volume":"13","author":"Tessari","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib71","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1084\/jem.20130592","article-title":"Inherited human OX40 deficiency underlying classic Kaposi sarcoma of childhood","volume":"210","author":"Byun","year":"2013","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib72","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1084\/jem.20101597","article-title":"Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma","volume":"207","author":"Byun","year":"2010","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib73","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jpeds.2003.11.012","article-title":"HHV-8-associated Kaposi sarcoma in a child with IFNgammaR1 deficiency","volume":"144","author":"Camcioglu","year":"2004","journal-title":"J Pediatr"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib74","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00431-006-0107-2","article-title":"Kaposi\u05f3s sarcoma in a child with Wiskott-Aldrich syndrome","volume":"165","author":"Picard","year":"2006","journal-title":"Eur J Pediatr"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib75","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1182\/blood-2005-03-0950","article-title":"Development of hemophagocytic lymphohistiocytosis in triplets infected with HHV-8","volume":"106","author":"Grossman","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib76","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1158\/1055-9965.EPI-05-0791","article-title":"Associations of classic Kaposi sarcoma with common variants in genes that modulate host immunity","volume":"15","author":"Brown","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib77","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1182\/blood.V96.7.2562","article-title":"An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus","volume":"96","author":"Foster","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib78","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1002\/cncr.22236","article-title":"Virologic, hematologic, and immunologic risk factors for classic Kaposi sarcoma","volume":"107","author":"Brown","year":"2006","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib79","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/QAD.0b013e3283601144","article-title":"Immunosenescence is associated with presence of Kaposi\u05f3s sarcoma in antiretroviral treated HIV infection","volume":"27","author":"Unemori","year":"2013","journal-title":"AIDS"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib80","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1093\/annonc\/mdn697","article-title":"The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman\u05f3s disease","volume":"20","author":"Powles","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib81","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/infdis\/jis249","article-title":"Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome","volume":"205","author":"Ray","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib82","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/29093","article-title":"Transformation of primary human endothelial cells by Kaposi\u05f3s sarcoma-associated herpesvirus","volume":"394","author":"Flore","year":"1998","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib83","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1126\/science.274.5293.1739","article-title":"Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV","volume":"274","author":"Moore","year":"1996","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib84","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1126\/science.278.5336.290","article-title":"Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines","volume":"278","author":"Boshoff","year":"1997","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib85","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1182\/blood.V97.10.3244","article-title":"Hypoxia induces lytic replication of Kaposi sarcoma-associated herpesvirus","volume":"97","author":"Davis","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib86","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/JVI.01742-10","article-title":"Oxidative stress induces reactivation of Kaposi\u05f3s sarcoma-associated herpesvirus and death of primary effusion lymphoma cells","volume":"85","author":"Li","year":"2011","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib87","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1128\/JVI.02024-06","article-title":"Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi\u05f3s sarcoma-associated herpesvirus: role of JAK\/STAT signaling","volume":"81","author":"Zeng","year":"2007","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib88","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1128\/JVI.02665-13","article-title":"Histone deacetylase classes I and II regulate Kaposi\u05f3s sarcoma-associated herpesvirus reactivation","volume":"88","author":"Shin","year":"2014","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib89","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/135965350501000609","article-title":"Prostratin and bortezomib are novel inducers of latent Kaposi\u05f3s sarcoma-associated herpesvirus","volume":"10","author":"Brown","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib90","doi-asserted-by":"crossref","first-page":"10866","DOI":"10.1073\/pnas.95.18.10866","article-title":"A viral gene that activates lytic cycle expression of Kaposi\u05f3s sarcoma-associated herpesvirus","volume":"95","author":"Sun","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib91","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/JVI.72.2.1005-1012.1998","article-title":"Transcription mapping of the Kaposi\u05f3s sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1)","volume":"72","author":"Sarid","year":"1998","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib92","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/JVI.71.1.715-719.1997","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells","volume":"71","author":"Staskus","year":"1997","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib93","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1126\/science.284.5414.641","article-title":"Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen","volume":"284","author":"Ballestas","year":"1999","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib94","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1128\/JVI.75.1.458-468.2001","article-title":"Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi\u05f3s sarcoma-associated herpesvirus","volume":"75","author":"Renne","year":"2001","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib95","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1128\/JVI.78.12.6585-6594.2004","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency","volume":"78","author":"Lan","year":"2004","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib96","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/47266","article-title":"p53 inhibition by the LANA protein of KSHV protects against cell death","volume":"402","author":"Friborg","year":"1999","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib97","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/80459","article-title":"The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells","volume":"6","author":"Radkov","year":"2000","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib98","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/nm829","article-title":"A novel viral mechanism for dysregulation of beta-catenin in Kaposi\u05f3s sarcoma-associated herpesvirus latency","volume":"9","author":"Fujimuro","year":"2003","journal-title":"Nat Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib99","doi-asserted-by":"crossref","first-page":"16287","DOI":"10.1073\/pnas.0703508104","article-title":"Kaposi\u05f3s sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein","volume":"104","author":"Lan","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib100","doi-asserted-by":"crossref","first-page":"e1000818","DOI":"10.1371\/journal.ppat.1000818","article-title":"Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency","volume":"6","author":"Sarek","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib101","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1128\/JVI.71.6.4193-4198.1997","article-title":"The cyclin encoded by Kaposi\u05f3s sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1","volume":"71","author":"Godden-Kent","year":"1997","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib102","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/emboj\/18.3.654","article-title":"Modulation of p27(Kip1) levels by the cyclin encoded by Kaposi\u05f3s sarcoma-associated herpesvirus","volume":"18","author":"Mann","year":"1999","journal-title":"EMBO J"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib103","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/386517a0","article-title":"Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors","volume":"386","author":"Thome","year":"1997","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib104","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1038\/sj.onc.1202976","article-title":"Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins","volume":"18","author":"Chaudhary","year":"1999","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib105","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1128\/JVI.01871-08","article-title":"Gene regulation and functional alterations induced by Kaposi\u05f3s sarcoma-associated herpesvirus-encoded ORFK13\/vFLIP in endothelial cells","volume":"83","author":"Sakakibara","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib106","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.20031467","article-title":"KSHV vFLIP is essential for the survival of infected lymphoma cells","volume":"199","author":"Guasparri","year":"2004","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib107","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.4049\/jimmunol.1202514","article-title":"Role of IRF4 in IFN-stimulated gene induction and maintenance of Kaposi sarcoma-associated herpesvirus latency in primary effusion lymphoma cells","volume":"191","author":"Forero","year":"2013","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib108","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/ncb1980","article-title":"FLIP-mediated autophagy regulation in cell death control","volume":"11","author":"Lee","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib109","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1128\/JVI.72.6.4980-4988.1998","article-title":"Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi\u05f3s sarcoma-associated herpesvirus) transforming gene","volume":"72","author":"Muralidhar","year":"1998","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib110","doi-asserted-by":"crossref","first-page":"e1001046","DOI":"10.1371\/journal.ppat.1001046","article-title":"Kaposin-B enhances the PROX1 mRNA stability during lymphatic reprogramming of vascular endothelial cells by Kaposi\u05f3s sarcoma herpes virus","volume":"6","author":"Yoo","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib111","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.1105779","article-title":"The kaposin B protein of KSHV activates the p38\/MK2 pathway and stabilizes cytokine mRNAs","volume":"307","author":"McCormick","year":"2005","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib112","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1128\/JVI.03315-12","article-title":"Distinct roles of Kaposi\u05f3s sarcoma-associated herpesvirus-encoded viral interferon regulatory factors in inflammatory response and cancer","volume":"87","author":"Baresova","year":"2013","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib113","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/JVI.75.1.429-438.2001","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53","volume":"75","author":"Rivas","year":"2001","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib114","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1182\/blood-2007-05-092288","article-title":"The viral interferon-regulatory factor-3 is required for the survival of KSHV-infected primary effusion lymphoma cells","volume":"111","author":"Wies","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib115","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1158\/0008-5472.CAN-07-2766","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression","volume":"68","author":"Shin","year":"2008","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib116","doi-asserted-by":"crossref","first-page":"9301","DOI":"10.1128\/JVI.79.14.9301-9305.2005","article-title":"Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi\u05f3s sarcoma-associated herpesvirus","volume":"79","author":"Samols","year":"2005","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib117","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.coviro.2013.05.013","article-title":"gamma-Herpesvirus-encoded miRNAs and their roles in viral biology and pathogenesis","volume":"3","author":"Zhu","year":"2013","journal-title":"Curr Opin Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib118","doi-asserted-by":"crossref","first-page":"e1003584","DOI":"10.1371\/journal.ppat.1003584","article-title":"Proteomic screening of human targets of viral microRNAs reveals functions associated with immune evasion and angiogenesis","volume":"9","author":"Gallaher","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib119","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1128\/JVI.01147-12","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor\/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression","volume":"86","author":"Abend","year":"2012","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1189\/jlb.0409251","article-title":"Pivotal advance: Kaposi\u05f3s sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes","volume":"87","author":"Qin","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib121","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1038\/sj.onc.1201571","article-title":"K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway","volume":"15","author":"Gao","year":"1997","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib122","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2006-05-024034","article-title":"Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells","volume":"109","author":"Lagos","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib123","doi-asserted-by":"crossref","first-page":"4530","DOI":"10.1128\/JVI.02123-10","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression","volume":"85","author":"Schmidt","year":"2011","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib124","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.4049\/jimmunol.168.3.1226","article-title":"Viral IFN-regulatory factors inhibit activation-induced cell death via two positive regulatory IFN-regulatory factor 1-dependent domains in the CD95 ligand promoter","volume":"168","author":"Kirchhoff","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib125","doi-asserted-by":"crossref","first-page":"8218","DOI":"10.1128\/JVI.70.11.8218-8223.1996","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi\u05f3s sarcoma and malignant lymphoma","volume":"70","author":"Cesarman","year":"1996","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib126","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1084\/jem.191.3.445","article-title":"Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi\u05f3s sarcoma","volume":"191","author":"Yang","year":"2000","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib127","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/385347a0","article-title":"Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation","volume":"385","author":"Arvanitakis","year":"1997","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib128","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/34193","article-title":"G-protein-coupled receptor of Kaposi\u05f3s sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator","volume":"391","author":"Bais","year":"1998","journal-title":"Nature"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib129","first-page":"4873","article-title":"The Kaposi\u05f3s sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha","volume":"60","author":"Sodhi","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib130","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ccr.2006.05.026","article-title":"The TSC2\/mTOR pathway drives endothelial cell transformation induced by the Kaposi\u05f3s sarcoma-associated herpesvirus G protein-coupled receptor","volume":"10","author":"Sodhi","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib131","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4049\/jimmunol.167.1.505","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant","volume":"167","author":"Schwarz","year":"2001","journal-title":"J Immunol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib132","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1126\/science.1074883","article-title":"Viral IL-6-induced cell proliferation and immune evasion of interferon activity","volume":"298","author":"Chatterjee","year":"2002","journal-title":"Science"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib133","doi-asserted-by":"crossref","first-page":"19625","DOI":"10.1074\/jbc.272.31.19625","article-title":"A Kaposi\u05f3s sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit","volume":"272","author":"Molden","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib134","doi-asserted-by":"crossref","first-page":"4034","DOI":"10.1182\/blood.V93.12.4034","article-title":"Angiogenesis and hematopoiesis induced by Kaposi\u05f3s sarcoma-associated herpesvirus-encoded interleukin-6","volume":"93","author":"Aoki","year":"1999","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib135","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1086\/654798","article-title":"An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without multicentric Castleman disease","volume":"51","author":"Uldrick","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib136","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1182\/blood-2013-08-519959","article-title":"Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease","volume":"122","author":"Polizzotto","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib137","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1182\/blood.V96.4.1599","article-title":"Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions","volume":"96","author":"Aoki","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib138","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1128\/JVI.01517-08","article-title":"Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6","volume":"83","author":"Chen","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib139","doi-asserted-by":"crossref","first-page":"10816","DOI":"10.1128\/JVI.02047-13","article-title":"Role of human herpesvirus 8 interleukin-6-activated gp130 signal transducer in primary effusion lymphoma cell growth and viability","volume":"87","author":"Cousins","year":"2013","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib140","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1182\/blood-2011-09-377705","article-title":"HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice","volume":"119","author":"Suthaus","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib141","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1148\/radiology.185.3.1438762","article-title":"High-attenuation lymphadenopathy in AIDS patients: significance of findings at CT","volume":"185","author":"Herts","year":"1992","journal-title":"Radiology"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib142","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MPH.0b013e31829cdd49","article-title":"Malignancies in South African children with HIV","volume":"36","author":"Davidson","year":"2014","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib143","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ng1383","article-title":"Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus","volume":"36","author":"Hong","year":"2004","journal-title":"Nat Genet"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib144","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2230.2009.03707.x","article-title":"Immunohistochemistry in Kaposi\u05f3s sarcoma","volume":"35","author":"Pantanowitz","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib145","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cellbi.2007.08.021","article-title":"Immunohistological evaluation of immune cell infiltrate in cutaneous Kaposi\u05f3s sarcoma","volume":"32","author":"Hussein","year":"2008","journal-title":"Cell Biol Int"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib146","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.0303-6987.2004.0132.x","article-title":"Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi\u05f3s sarcoma","volume":"31","author":"Pantanowitz","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib147","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi\u05f3s sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee","volume":"7","author":"Krown","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib148","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","article-title":"AIDS-related Kaposi\u05f3s sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee","volume":"15","author":"Krown","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib149","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/QAI.0b013e318251aedd","article-title":"A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa","volume":"60","author":"Mosam","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib150","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.2003.10.162","volume":"21","author":"Nasti","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib151","doi-asserted-by":"crossref","first-page":"e64392","DOI":"10.1371\/journal.pone.0064392","article-title":"Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study","volume":"8","author":"Maskew","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib152","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-199910220-00014","article-title":"Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi\u05f3s sarcoma","volume":"13","author":"Bower","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib153","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.bjc.6603056","article-title":"Remission from Kaposi\u05f3s sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy","volume":"94","author":"Martinez","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib154","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposi\u05f3s sarcoma in renal-transplant recipients","volume":"352","author":"Stallone","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib155","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1200\/JCO.1996.14.8.2353","article-title":"Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi\u05f3s sarcoma","volume":"14","author":"Gill","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib156","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1200\/JCO.1998.16.7.2445","article-title":"Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi\u05f3s sarcoma: results of a randomized phase III clinical trial","volume":"16","author":"Northfelt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib157","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1200\/JCO.1998.16.2.683","article-title":"Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi\u05f3s sarcoma. International Pegylated Liposomal Doxorubicin Study Group","volume":"16","author":"Stewart","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib158","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1634\/theoncologist.12-1-114","article-title":"A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi\u05f3s sarcoma","volume":"12","author":"Cooley","year":"2007","journal-title":"Oncologist"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib159","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1200\/JCO.1998.16.3.1112","article-title":"Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi\u05f3s sarcoma","volume":"16","author":"Welles","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib160","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/cncr.10634","article-title":"Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma","volume":"95","author":"Tulpule","year":"2002","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib161","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1002\/cncr.25362","article-title":"Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy","volume":"116","author":"Cianfrocca","year":"2010","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib162","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/107999002753675712","article-title":"Efficacy of low-dose interferon with antiretroviral therapy in Kaposi\u05f3s sarcoma: a randomized phase II AIDS clinical trials group study","volume":"22","author":"Krown","year":"2002","journal-title":"J Interferon Cytokine Res"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib163","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1200\/JCO.1998.16.5.1736","article-title":"Prospective randomized trial of two dose levels of interferon alfa with zidovudine for the treatment of Kaposi\u05f3s sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network study","volume":"16","author":"Shepherd","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib164","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1200\/JCO.2002.12.038","article-title":"Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi\u05f3s sarcoma: an AIDS Clinical Trials Group clinical study","volume":"20","author":"Evans","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib165","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1200\/JCO.1997.15.5.2118","article-title":"Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi\u05f3s sarcoma with no prior exposure to cytotoxic therapy","volume":"15","author":"Schwartsmann","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib166","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1200\/JCO.2000.18.7.1550","article-title":"Vinorelbine is an effective and safe drug for AIDS-related Kaposi\u05f3s sarcoma: results of a phase II study","volume":"18","author":"Nasti","year":"2000","journal-title":"J Clin Oncol"},{"issue":"8966","key":"10.1053\/j.seminoncol.2014.12.027_bib167","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0140-6736(95)92654-2","article-title":"Treatment of HIV-associated Kaposi's sarcoma with paclitaxel","volume":"346","author":"Saville","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib168","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.1999.17.6.1876","article-title":"Paclitaxel is safe and effective in the treatment of advanced AIDS- related Kaposi\u05f3s sarcoma","volume":"17","author":"Gill","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib169","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.qai.0000194237.15831.23","article-title":"Interferon-alpha2b with protease inhibitor-based antiretroviral therapy in patients with AIDS-associated Kaposi sarcoma: an AIDS malignancy consortium phase I trial","volume":"41","author":"Krown","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib170","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1258\/0956462981921512","article-title":"Activity of thalidomide in AIDS-related Kaposi\u05f3s sarcoma and correlation with HHV8 titre","volume":"9","author":"Fife","year":"1998","journal-title":"Int J STD AIDS"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib171","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1200\/JCO.2000.18.13.2593","article-title":"Activity of thalidomide in AIDS-related Kaposi\u05f3s sarcoma","volume":"18","author":"Little","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib172","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/QAI.0b013e31823e7884","article-title":"Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study","volume":"59","author":"Krown","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib173","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi\u05f3s sarcoma: an AIDS Malignancy Consortium Study","volume":"24","author":"Dezube","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib174","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1200\/JCO.2012.48.6365","article-title":"Phase II trial of imatinib in AIDS-associated Kaposi\u05f3s sarcoma: AIDS Malignancy Consortium Protocol 042","volume":"32","author":"Koon","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib175","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2011.39.6853","article-title":"Phase II study of bevacizumab in patients with HIV-associated Kaposi\u05f3s sarcoma receiving antiretroviral therapy","volume":"30","author":"Uldrick","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib176","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI119380","article-title":"Sensitivity of Kaposi\u05f3s sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy","volume":"99","author":"Kedes","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib177","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib178","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00002030-199601000-00009","article-title":"Multicentric Castleman\u05f3s disease in HIV infection: a clinical and pathological study of 20 patients","volume":"10","author":"Oksenhendler","year":"1996","journal-title":"AIDS"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib179","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1182\/blood.V96.6.2069","article-title":"High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients","volume":"96","author":"Oksenhendler","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib180","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1038\/sj.onc.1206407","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus encoded vFLIP induces cellular IL-6 expression: the role of the NF-kappaB and JNK\/AP1 pathways","volume":"22","author":"An","year":"2003","journal-title":"Oncogene"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib181","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2005-07-2730","article-title":"NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo","volume":"107","author":"Keller","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib182","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1182\/blood.V97.8.2526","article-title":"Serum viral interleukin-6 in AIDS-related multicentric Castleman disease","volume":"97","author":"Aoki","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib183","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fmicb.2012.00073","article-title":"Clinical manifestations of Kaposi sarcoma herpesvirus lytic activation: multicentric Castleman disease (KSHV-MCD) and the KSHV inflammatory cytokine syndrome","volume":"3","author":"Polizzotto","year":"2012","journal-title":"Front Microbiol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib184","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1182\/blood.V97.7.2130","article-title":"Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders","volume":"97","author":"Du","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib185","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/PAS.0b013e318160ed97","article-title":"Lymph nodes involved by multicentric Castleman disease among HIV-positive individuals are often involved by Kaposi sarcoma","volume":"32","author":"Naresh","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib186","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/CCO.0b013e328355e0f3","article-title":"Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease","volume":"24","author":"Uldrick","year":"2012","journal-title":"Curr Opin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib187","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/QAI.0b013e3182a8338f","article-title":"Diagnostic criteria schemes for multicentric Castleman disease in 75 cases","volume":"65","author":"Bower","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib188","first-page":"25","article-title":"Multicentric Castleman\u05f3s disease in HIV infection: a systematic review of the literature","volume":"10","author":"Mylona","year":"2008","journal-title":"AIDS Rev"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib189","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.1128\/JVI.01587-07","article-title":"Human herpesvirus 8 infects and replicates in primary cultures of activated B lymphocytes through DC-SIGN","volume":"82","author":"Rappocciolo","year":"2008","journal-title":"J Virol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib190","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1182\/blood-2011-08-376012","article-title":"Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease","volume":"119","author":"Gerard","year":"2012","journal-title":"Blood"},{"issue":"24","key":"10.1053\/j.seminoncol.2014.12.027_bib191","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1182\/blood-2014-07-586800","article-title":"Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease","volume":"124","author":"Uldrick","year":"2014","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib192","doi-asserted-by":"crossref","first-page":"7003","DOI":"10.1158\/0008-5472.CAN-07-0939","article-title":"Hypoxia enhances the phosphorylation and cytotoxicity of ganciclovir and zidovudine in Kaposi\u05f3s sarcoma-associated herpesvirus infected cells","volume":"67","author":"Davis","year":"2007","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib193","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1182\/blood-2010-11-317610","article-title":"High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy","volume":"117","author":"Uldrick","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib194","doi-asserted-by":"crossref","first-page":"10399","DOI":"10.1073\/pnas.1630810100","article-title":"Kaposi\u05f3s sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile","volume":"100","author":"Jenner","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib195","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1182\/blood-2002-10-3090","article-title":"Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts","volume":"101","author":"Klein","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib196","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/path.2752","article-title":"Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration","volume":"222","author":"Luan","year":"2010","journal-title":"J Pathol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib197","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u05f3s sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib198","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1200\/JCO.2005.07.084","article-title":"Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS","volume":"23","author":"Boulanger","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib199","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","article-title":"KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma","volume":"28","author":"Chadburn","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib200","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3109\/10428194.2012.747680","article-title":"Human herpesvirus 8- and Epstein-Barr virus-associated solitary B cell lymphoma with a T cell immunophenotype","volume":"54","author":"Dong","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib201","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/leu.2009.117","article-title":"Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma","volume":"23","author":"Gasperini","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2014.12.027_bib202","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1182\/blood-2013-01-481713","article-title":"CD30 targeting with brentuximab vedotin: a novel therapeutic approach to primary effusion lymphoma","volume":"122","author":"Bhatt","year":"2013","journal-title":"Blood"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377541400298X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009377541400298X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T04:42:01Z","timestamp":1651639321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009377541400298X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":202,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S009377541400298X"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2014.12.027","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}